{"id":25204,"date":"2026-05-02T08:56:22","date_gmt":"2026-05-02T08:56:22","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/25204\/"},"modified":"2026-05-02T08:56:22","modified_gmt":"2026-05-02T08:56:22","slug":"bytedances-drug-unit-presents-ai-designed-therapies-at-global-conferences","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/25204\/","title":{"rendered":"ByteDance\u2019s drug unit presents AI-designed therapies at global conferences"},"content":{"rendered":"<p><a target=\"_self\" class=\"e1yy41x40 ef9u0v01 css-1ankfgb ecgc78b0\" href=\"https:\/\/www.scmp.com\/tech\/big-tech\/article\/3349337\/bytedance-valuation-surges-record-high-over-us600b-proposed-equity-sale-sources?module=inline&amp;pgtype=article\" title=\"\" data-qa=\"BaseLink-renderAnchor-StyledAnchor\" rel=\"nofollow noopener\">ByteDance<\/a>, the Chinese owner of TikTok, is pushing deeper into artificial intelligence with Anew Labs, a drug-discovery unit that has begun presenting its AI-designed therapies at international conferences.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">The unit \u2013 also known as Anew Therapeutics or ByteDance AI Drug Discovery \u2013 operates from Shanghai, Singapore and San Jose, California.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">Its official website listed 36 core members, as well as big names on its \u201cscientific advisory board\u201d: Liu Yongjun, former president of Innovent Biologics, Ji Ma, a former principal scientist at biotech company Amgen, and Hua Zou, scientific director of protein chemistry at Takeda California.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">In mid-April, Chris Li, head of biology, presented one of Anew Labs\u2019 four pipeline drug candidates at Immunology2026 in Boston, organised by the American Association of Immunologists. The treatment was designed by generative AI for certain autoimmune diseases.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">She Yuli, head of data, joined the International Conference on Learning Representations, in late April in Rio de Janeiro, according to She\u2019s LinkedIn post. The conference was a gathering of professionals dedicated to the advancement of deep learning.<\/p>\n<p><img decoding=\"async\" alt=\"ByteDance\u2019s Anew Labs lists 36 core members, as well as big names on its scientific advisory board. Photo: Shutterstock\" data-qa=\"BaseImage-handleRenderImage-StyledImage\" class=\"e1gf69pb2 css-6ikqhs e445x7d0\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/05\/e4bac3b4-782c-47cd-8a52-817451f2d828_c79ce972.jpg\" title=\"ByteDance\u2019s Anew Labs lists 36 core members, as well as big names on its scientific advisory board. Photo: Shutterstock\"\/>ByteDance\u2019s Anew Labs lists 36 core members, as well as big names on its scientific advisory board. Photo: Shutterstock<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">Yu Haoyu, head of computational chemistry, said on LinkedIn that he would be in Barcelona, Spain, for the 2026 Free Energy Workshop, which is for AI chemistry and kicks off on May 4. He planned to present AnewSampling, a framework to reproduce molecular dynamics at the all-atom level.<\/p>\n","protected":false},"excerpt":{"rendered":"ByteDance, the Chinese owner of TikTok, is pushing deeper into artificial intelligence with Anew Labs, a drug-discovery unit&hellip;\n","protected":false},"author":2,"featured_media":25205,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24,17037,17035,17032,25,6657,580,387,11794,5887,17033,2225,157,17030,3119,17036,17034,17031],"class_list":{"0":"post-25204","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ai","8":"tag-ai","9":"tag-amgen","10":"tag-anew-labs","11":"tag-anew-therapeutics","12":"tag-artificial-intelligence","13":"tag-bytedance","14":"tag-chatgpt","15":"tag-china","16":"tag-drug","17":"tag-hollywood","18":"tag-innovent-biologics","19":"tag-llms","20":"tag-openai","21":"tag-paramount-pictures","22":"tag-pharmaceutical","23":"tag-seedance","24":"tag-tsinghua-university","25":"tag-walt-disney-studios"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/25204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=25204"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/25204\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/25205"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=25204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=25204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=25204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}